Table 1.
Characteristic | Males | Females | Total |
Sex | 8 | 21 | 29 |
Race | |||
Caucasian | 7 | 16 | 23 |
African American | 1 | 4 | 5 |
Other/unknown | 0 | 1 | 1 |
Presence of | |||
Diabetes | 3 | 15 | 18 |
Hypertension | 8 | 17 | 25 |
Obesity | 5 | 10 | 15 |
Reason for PCSK-9 inhibitor initiation | |||
Statin intolerance | 4 | 16 | 20 |
Inadequate lipid control | 2 | 4 | 6 |
Not known | 2 | 1 | 3 |
PCSK9: Proprotein convertase subtilisin/kexin type-9.